Tonix Pharmaceuticals Holding Corp.
TNXP
$12.83
-$0.33-2.51%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -40.55M | -40.19M | -46.91M | -32.01M | -28.27M |
| Total Depreciation and Amortization | 619.00K | 555.00K | 488.00K | 461.00K | 483.00K |
| Total Amortization of Deferred Charges | -- | -- | 0.00 | 0.00 | 0.00 |
| Total Other Non-Cash Items | 2.26M | 1.97M | 1.14M | 2.15M | 5.54M |
| Change in Net Operating Assets | -4.57M | -4.65M | 5.63M | 616.00K | 7.42M |
| Cash from Operations | -42.24M | -42.32M | -39.65M | -28.78M | -14.83M |
| Capital Expenditure | -587.00K | -1.69M | -1.87M | -962.00K | -527.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 853.00K | 0.00 | -2.01M |
| Cash from Investing | -587.00K | -1.69M | -1.02M | -962.00K | -2.54M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 0.00 | 0.00 | 0.00 |
| Issuance of Common Stock | 34.55M | 20.88M | 69.95M | 97.85M | 14.38M |
| Repurchase of Common Stock | -- | -- | -7.81M | 0.00 | -2.90M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.05M | -676.00K | -3.00M | -2.99M | -487.00K |
| Cash from Financing | 33.51M | 20.21M | 59.14M | 94.86M | 10.99M |
| Foreign Exchange rate Adjustments | -64.00K | 6.00K | -14.00K | -4.00K | -4.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.39M | -23.80M | 18.46M | 65.11M | -6.38M |